TY - JOUR AU - Flaherty, K. T. AU - Puzanov, I. AU - Kim, K. B. AU - Ribas, A. AU - McArthur, G. A. AU - Sosman, J. A. PY - 2010 DA - 2010// TI - Inhibition of mutated, activated BRAF in metastatic melanoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1002011 DO - 10.1056/NEJMoa1002011 ID - Flaherty2010 ER - TY - JOUR AU - Kris, M. G. AU - Natale, R. B. AU - Herbst, R. S. AU - Lynch, T. J. AU - JR, P. D. AU - Belani, C. P. PY - 2003 DA - 2003// TI - Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.16.2149 DO - 10.1001/jama.290.16.2149 ID - Kris2003 ER - TY - JOUR AU - Perez, E. A. AU - Romond, E. H. AU - Suman, V. J. AU - Jeong, J. -. H. AU - Davidson, N. E. AU - Geyer, C. E. PY - 2011 DA - 2011// TI - Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31 JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.0868 DO - 10.1200/JCO.2011.35.0868 ID - Perez2011 ER - TY - JOUR AU - Ciriello, G. AU - Miller, M. L. AU - Aksoy, B. A. AU - Senbabaoglu, Y. AU - Schultz, N. AU - Sander, C. PY - 2013 DA - 2013// TI - Emerging landscape of oncogenic signatures across human cancers JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2762 DO - 10.1038/ng.2762 ID - Ciriello2013 ER - TY - JOUR AU - Hoadley, K. A. AU - Yau, C. AU - Wolf, D. M. AU - Cherniack, A. D. AU - Tamborero, D. AU - Ng, S. PY - 2014 DA - 2014// TI - Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin JO - Cell VL - 158 UR - https://doi.org/10.1016/j.cell.2014.06.049 DO - 10.1016/j.cell.2014.06.049 ID - Hoadley2014 ER - TY - JOUR AU - Weinstein, J. N. AU - Collisson, E. A. AU - Mills, G. B. AU - Shaw, K. R. AU - Ozenberger, B. A. AU - Ellrott, K. PY - 2013 DA - 2013// TI - The Cancer Genome Atlas pan-cancer analysis project JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2764 DO - 10.1038/ng.2764 ID - Weinstein2013 ER - TY - JOUR AU - Bang, Y. -. J. AU - van Cutsem, E. AU - Feyereislova, A. AU - Chung, H. C. AU - Shen, L. AU - Sawaki, A. PY - 2010 DA - 2010// TI - Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61121-X DO - 10.1016/S0140-6736(10)61121-X ID - Bang2010 ER - TY - JOUR AU - Rugo, H. S. AU - Barve, A. AU - Waller, C. F. AU - Hernandez-Bronchud, M. AU - Herson, J. AU - Yuan, J. PY - 2017 DA - 2017// TI - Effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with ERBB2 (HER2)-positive metastatic breast cancer: a randomized clinical trial JO - JAMA VL - 317 UR - https://doi.org/10.1001/jama.2016.18305 DO - 10.1001/jama.2016.18305 ID - Rugo2017 ER - TY - JOUR AU - Carvajal, R. D. AU - Lawrence, D. P. AU - Weber, J. S. AU - Gajewski, T. F. AU - Gonzalez, R. AU - Lutzky, J. PY - 2015 DA - 2015// TI - Phase II study of nilotinib in melanoma harboring KIT alterations following progression to prior KIT inhibition JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1630 DO - 10.1158/1078-0432.CCR-14-1630 ID - Carvajal2015 ER - TY - JOUR AU - Macleod, A. C. AU - Klug, L. R. AU - Patterson, J. AU - Griffith, D. J. AU - Beadling, C. AU - Town, A. AU - Heinrich, M. C. PY - 2014 DA - 2014// TI - Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity JO - Mol Cancer Ther VL - 13 UR - https://doi.org/10.1158/1535-7163.MCT-13-0830 DO - 10.1158/1535-7163.MCT-13-0830 ID - Macleod2014 ER - TY - JOUR AU - Souglakos, J. AU - Philips, J. AU - Wang, R. AU - Marwah, S. AU - Silver, M. AU - Tzardi, M. PY - 2009 DA - 2009// TI - Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605164 DO - 10.1038/sj.bjc.6605164 ID - Souglakos2009 ER - TY - JOUR AU - Yokota, T. AU - Ura, T. AU - Shibata, N. AU - Takahari, D. AU - Shitara, K. AU - Nomura, M. PY - 2011 DA - 2011// TI - BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer JO - Br J Cancer VL - 104 UR - https://doi.org/10.1038/bjc.2011.19 DO - 10.1038/bjc.2011.19 ID - Yokota2011 ER - TY - JOUR AU - Hyman, D. M. AU - Puzanov, I. AU - Subbiah, V. AU - Faris, J. E. AU - Chau, I. AU - Blay, J. -. Y. PY - 2015 DA - 2015// TI - Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1502309 DO - 10.1056/NEJMoa1502309 ID - Hyman2015 ER - TY - JOUR AU - Lopez-Chavez, A. AU - Thomas, A. AU - Rajan, A. AU - Raffeld, M. AU - Morrow, B. AU - Kelly, R. PY - 2015 DA - 2015// TI - Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.2007 DO - 10.1200/JCO.2014.58.2007 ID - Lopez-Chavez2015 ER - TY - JOUR AU - Ramos, A. H. AU - Lichtenstein, L. AU - Gupta, M. AU - Lawrence, M. S. AU - Pugh, T. J. AU - Saksena, G. PY - 2015 DA - 2015// TI - Oncotator: cancer variant annotation tool JO - Hum Mutat VL - 36 UR - https://doi.org/10.1002/humu.22771 DO - 10.1002/humu.22771 ID - Ramos2015 ER - TY - BOOK PY - 2016 DA - 2016// TI - Analysis-ready standardized TCGA data from Broad GDAC Firehose stddata__2015_11_01 run: Broad Institute of MIT and Harvard ID - ref16 ER - TY - JOUR AU - Li, J. AU - Lu, Y. AU - Akbani, R. AU - Ju, Z. AU - Roebuck, P. L. AU - Liu, W. PY - 2013 DA - 2013// TI - TCPA: a resource for cancer functional proteomics data JO - Nat Meth VL - 10 UR - https://doi.org/10.1038/nmeth.2650 DO - 10.1038/nmeth.2650 ID - Li2013 ER - TY - JOUR AU - Heim, D. AU - Budczies, J. AU - Stenzinger, A. AU - Treue, D. AU - Hufnagl, P. AU - Denkert, C. PY - 2014 DA - 2014// TI - Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers JO - Int J Cancer VL - 135 UR - https://doi.org/10.1002/ijc.28882 DO - 10.1002/ijc.28882 ID - Heim2014 ER - TY - JOUR AU - Kim, N. AU - Hong, Y. AU - Kwon, D. AU - Yoon, S. PY - 2013 DA - 2013// TI - Somatic mutaome profile in human cancer tissues JO - Genomics Inform VL - 11 UR - https://doi.org/10.5808/GI.2013.11.4.239 DO - 10.5808/GI.2013.11.4.239 ID - Kim2013 ER - TY - JOUR AU - Kim, Y. -. A. AU - Madan, S. AU - Przytycka, T. M. PY - 2017 DA - 2017// TI - WeSME: uncovering mutual exclusivity of cancer drivers and beyond JO - Bioinformatics VL - 33 UR - https://doi.org/10.1093/bioinformatics/btw242. DO - 10.1093/bioinformatics/btw242. ID - Kim2017 ER - TY - JOUR AU - Lawrence, M. S. AU - Stojanov, P. AU - Polak, P. AU - Kryukov, G. V. AU - Cibulskis, K. AU - Sivachenko, A. PY - 2013 DA - 2013// TI - Mutational heterogeneity in cancer and the search for new cancer genes JO - Nature VL - 499 UR - https://doi.org/10.1038/nature12213. DO - 10.1038/nature12213. ID - Lawrence2013 ER - TY - JOUR AU - Ricciuti, B. AU - Brambilla, M. AU - Metro, G. AU - Baglivo, S. AU - Matocci, R. AU - Pirro, M. AU - Chiari, R. PY - 2017 DA - 2017// TI - Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence JO - Med Oncol VL - 34 UR - https://doi.org/10.1007/s12032-017-0967-5 DO - 10.1007/s12032-017-0967-5 ID - Ricciuti2017 ER - TY - STD TI - Chakravarty D, Gao J, Phillips S, Kundra R, Zhang H, Wang J, et al. OncoKB: a precision oncology knowledge base. JCO Precis Oncol. 2017:1–16. https://doi.org/10.1200/PO.17.00011. ID - ref23 ER - TY - JOUR AU - Hu, X. AU - Wang, Q. AU - Tang, M. AU - Barthel, F. AU - Amin, S. AU - Yoshihara, K. PY - 2018 DA - 2018// TI - TumorFusions: an integrative resource for cancer-associated transcript fusions JO - Nucleic Acids Res VL - 46 UR - https://doi.org/10.1093/nar/gkx1018 DO - 10.1093/nar/gkx1018 ID - Hu2018 ER - TY - JOUR AU - Yuan, Y. AU - van Allen, E. M. AU - Omberg, L. AU - Wagle, N. AU - Amin-Mansour, A. AU - Sokolov, A. PY - 2014 DA - 2014// TI - Assessing the clinical utility of cancer genomic and proteomic data across tumor types JO - Nat Biotechnol VL - 32 UR - https://doi.org/10.1038/nbt.2940 DO - 10.1038/nbt.2940 ID - Yuan2014 ER - TY - JOUR AU - Akbani, R. AU - Ng, P. K. AU - Werner, H. M. AU - Shahmoradgoli, M. AU - Zhang, F. AU - Ju, Z. PY - 2014 DA - 2014// TI - A pan-cancer proteomic perspective on The Cancer Genome Atlas JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4887 DO - 10.1038/ncomms4887 ID - Akbani2014 ER - TY - JOUR AU - Morris, L. G. AU - Riaz, N. AU - Desrichard, A. AU - Senbabaoglu, Y. AU - Hakimi, A. A. AU - Makarov, V. PY - 2016 DA - 2016// TI - Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7067 DO - 10.18632/oncotarget.7067 ID - Morris2016 ER - TY - JOUR AU - Andor, N. AU - Graham, T. A. AU - Jansen, M. AU - Xia, L. C. AU - Aktipis, C. A. AU - Petritsch, C. PY - 2016 DA - 2016// TI - Pan-cancer analysis of the extent and consequences of intratumor heterogeneity JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.3984 DO - 10.1038/nm.3984 ID - Andor2016 ER - TY - JOUR AU - Smirnov, P. AU - Safikhani, Z. AU - El-Hachem, N. AU - Wang, D. AU - She, A. AU - Olsen, C. PY - 2016 DA - 2016// TI - PharmacoGx: an R package for analysis of large pharmacogenomic datasets JO - Bioinformatics VL - 32 UR - https://doi.org/10.1093/bioinformatics/btv723 DO - 10.1093/bioinformatics/btv723 ID - Smirnov2016 ER -